Evidence map›Paper›PMID 37124764›Full record

ReviewFrontiers in public health2023

Planning, implementation, and sustaining high coverage of human papillomavirus (HPV) vaccination programs: What works in the context of low-resource countries?

Dur-E-Nayab Waheed, Ana Bolio, Dominique Guillaume, Anissa Sidibe, Christopher Morgan, Emilie Karafillakis, Megan Holloway, Pierre Van Damme, Rupali Limaye, Alex Vorsters

Abstract readReview
In one paragraph

Review in Frontiers in public health, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dur-E-Nayab WaheedCentre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium.
Ana BolioDepartment of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Dominique GuillaumeJhpiego, The Johns Hopkins University Affiliate, Baltimore, MD, United States.
Anissa SidibeDepartment of Vaccine Programmes, Gavi, the Vaccine Alliance, Geneva, Switzerland.
Christopher MorganJhpiego, The Johns Hopkins University Affiliate, Baltimore, MD, United States.
Emilie KarafillakisCentre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium.
Megan HollowayDepartment of Vaccine Programmes, Gavi, the Vaccine Alliance, Geneva, Switzerland.
Pierre Van DammeCentre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium.
Rupali LimayeInternational Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, United States.
Alex VorstersCentre for the Evaluation of Vaccination, University of Antwerp, Antwerp, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical cancer due to human papillomavirus (HPV) infection is a leading cause of mortality among women in low-resource settings. Many Sub-Saharan African countries have introduced HPV vaccination programs at the national level in the last few years. However, countries are struggling to maintain sustainable coverage. This study focuses on the introduction and sustainability challenges, context-specific key lessons learned, and mechanisms of action to achieve high sustainable coverage from low and lower-middle-income countries (LLMICs) that have introduced HPV vaccination programs by collating evidence from a literature review and key informant interviews. Local data availability was a challenge across countries, with the lack or absence of registries, data collection and reporting mechanisms. Multi-sectoral coordination and early involvement of key stakeholders were cited as an integral part of HPV programs and facilitators for sustainable coverage. Key informants identified periodic sensitization and training as critical due to high staff turnover. Health workforce mobilization was fundamental to ensure that the health workforce is aware of the disease etiology, eligibility requirements, and can dispel misinformation. Schools were reported to be an ideal sustainable platform for vaccination. However, this required teachers to be trained, which was often not considered in the programs. District-level staff were often poorly informed and lacked the technical and logistic capacity to support vaccination rounds and data collection. To improve the sustainability of HPV vaccination programs, there is a need for timely microplanning, efficient preparedness assessment, assessing training approaches, periodic training, finding innovative ways to achieve equity and adoption of a bottom-up approach to ensure that processes between districts and central level are well-connected and resources are distributed efficiently.

Indexed as

Papillomavirus InfectionsUterine Cervical NeoplasmsFemaleHuman Papillomavirus VirusesHumansImmunization ProgramsVaccinationbarriers and facilitating factorsHPV vaccinationhuman papillomaviruslow-and lower-middle-income countriesvaccine implementation

Identifiers

PMID37124764
PMCPMC10140426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.